Do metabolic pathways exist for xenobiotics? The micro-metabolism hypothesis

Xenobiotica

Volumn 33, Issue 9, 2003, Pages 887-901

  Wilson, I D ^a   Nicholson, J K ^b  

^a ASTRAZENECA   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANILINE DERIVATIVE; ENZYME; XENOBIOTIC AGENT;

ANALYTIC METHOD; ARTICLE; BINDING AFFINITY; BIOTRANSFORMATION; CHEMISTRY; METABOLISM; METABOLITE; NONHUMAN; PROTEIN FUNCTION; ANIMAL; HUMAN; REVIEW;

ANIMALS; BIOTRANSFORMATION; HUMANS; XENOBIOTICS;

EID: 0141953673     PISSN: 00498254     EISSN: None     Source Type: Journal    
DOI: 10.1080/00498250310001598221     Document Type: Article

References (13)

1. ABOU-SHAKRA, F., SAGE, A. B., CASTRO-PEREZ, J., NICHOLSON, J. K. LINDON, J. C., SCARFE, G. B and WILSON, I. D., 2002, High-performance liquid chromatography-UV diode array, inductively coupled plasma mass spectrometry (ICPMS) and orthogonal acceleration time-of-flight mass spectrometry (oa-TOF-MS) applied to the simultaneous detection and identification of metabolites of 4-bromoaniline in rat urine. Chromatographia, 55, S9-S13.
2. BAILLIE, T. A., CAYEN, M. N., FOUDA, H., GERSON, R. J., GREEN, J. D., GROSSMAN, S. J., KLUNK, L. J., LEBLANC, B., PERKINS, D. G. and SHIPLEY, L. A., 2002, Drug metabolites in safety testing, Toxicology and Applied Pharmacology, 182, 188-196.
3. DAVY, H., 1840, Collected Works, vol. IV (London).
4. HUCKER, H. B., KWAN, K. C. and DUGGAN, D. E., 1980, Pharmacokinetics and metabolism of non-steroidal anti-inflammatory agents. In J. W. Bridges and L. F. Chasseaud (eds), Progress in Drug Metabolism (Chichester: Wiley), vol. 5, pp. 165-253.
5. LI, A. P., 2002, A review of the common properties of drugs with idiosyncratic hepatoxicity and the 'multiple determinant hypothesis' for the manifestation of idiosyncratic drug toxicity, 142, 7-23.
6. MAJOR, H., CASTRO-PEREZ, J., NICHOLSON, J. and WILSON, I. D., In press, Detection of mono- and di-hexoses as metabolites of 4-bromoaniline using exact mass neutral loss acquisitions by HPLC-TOF-MS/MS. Xenobiotica.
7. MAJOR, H., CASTRO-PEREZ, J., NICHOLSON, J. K. and WILSON, I. D., 2002, Characterisation of putative pentose-containing conjugates as minor metabolites of 4-bromoaniline present in the urine of rats following intraperitoneal administration. Rapid Communications in Mass Spectrometry, 17, 76-80.
8. NICHOLLS, A. W., FARRANT, R. D., SHOCKOR, J. P., UNGER, S. E., WILSON, I. D., LINDON, J. C. and NICHOLSON, J. K., 1997, NMR and HPLC-NMR studies on the metabolism and futile deacetylation of paracetamol metabolites in rat and man, Biochemical Pharmacology, 49, 1155-1164.
9. NICHOLSON, J. K., CONNELLY, J. LINDON J. C. and HOLMES, E., 2002, Metabonomics a platform for studying drug toxicity and gene function. Nature Reviews, Drug Discovery, 1, 153-161.
10. NICHOLSON, J. K., LINDON, J. C., SCARFE, G., WILSON, I. D., ABOU-SHAKRA, F., CASTR-PEREZ, J., EATON, A and PREECE, S., 2000, High-performance liquid chromatography and inductively coupled plasma mass spectrometry (HPLC-ICPMS) for the analysis of xenobiotic metabolites in rat urine: application to the metabolites of 4-bromoaniline. Analyst, 125, 235-236.
11. 13C]-acetanilide in rat. Xenobiotica, 32, 325-337.
12. TESTA, B. and JENNER, P., 1978, Novel drug metabolites produced by functionalisation reactions: chemistry and toxicology. Drug Metabolism Reviews, 7, 325-369.
13. WILLIAMS, R. T., 1947, Detoxication Mechanisms (London: Chapman & Hall).